Los Angeles Capital Management’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.3M | Sell |
71,374
-51,670
| -42% | -$941K | ﹤0.01% | 579 |
|
|
2025
Q1 | $2.44M | Buy |
123,044
+39,804
| +48% | +$790K | 0.01% | 371 |
|
|
2024
Q4 | $1.43M | Sell |
83,240
-65,250
| -44% | -$1.12M | 0.01% | 524 |
|
|
2024
Q3 | $2.97M | Buy |
148,490
+67,740
| +84% | +$1.35M | 0.01% | 387 |
|
|
2024
Q2 | $903K | Buy |
+80,750
| New | +$903K | ﹤0.01% | 685 |
|
|
2021
Q3 | – | Sell |
-37,165
| Closed | -$59K | – | 1462 |
|
|
2021
Q2 | $59K | Sell |
37,165
-2,100
| -5% | -$3.33K | ﹤0.01% | 1516 |
|
|
2021
Q1 | $69K | Sell |
39,265
-34,100
| -46% | -$59.9K | ﹤0.01% | 1570 |
|
|
2020
Q4 | $143K | Buy |
73,365
+50
| +0.1% | +$97 | ﹤0.01% | 1489 |
|
|
2020
Q3 | $175K | Sell |
73,315
-9,830
| -12% | -$23.5K | ﹤0.01% | 1403 |
|
|
2020
Q2 | $244K | Buy |
83,145
+57,010
| +218% | +$167K | ﹤0.01% | 1344 |
|
|
2020
Q1 | $75K | Buy |
+26,135
| New | +$75K | ﹤0.01% | 1310 |
|